New Solutions for Assessing Corporate Social Responsibility in Pharmaceutical Companies: A Mathematical Modelling Approach

The paper aims to identify the influencing factors of social performance in the pharmaceutical sector (from a sample of 6 companies listed on the Bucharest Stock Exchange during [2011][2012][2013][2014][2015][2016][2017][2018][2019][2020].The research methods refer to identifying the non-financial and financial information whose reporting by pharmaceutical companies produces significant effects on social performance based on the analysis of the database and the econometric model.Our primary findings are that, while raising the rate of return on equitythe primary financial indicatorcauses social performance to decline, human capital development, and company size are believed to boost social performance.When it comes to social performance, nonfinancial factors are more important than financial ones.Spending on the environment has the greatest impact on social performance.Also, the econometric model demonstrates how variations in gender within the board of directors may either boost or decrease social performance.